Breast Cancer Clinical Trial

Tissue Oxygenation Measurements With Modulated Light (S-FLARE)

Summary

To perform a pilot study of the S-FLARE imaging system, which uses low levels of safe, invisible, near-infrared light to measure tissue oxygenation during breast reconstructive surgery and to compare S-FLARE measurements to the gold standard, FDA-approved, the ViOptix optical probe.

View Full Description

Full Description

This pilot study will enroll three patients who have chosen to proceed with deep inferior epigastric perforator (DIEP) flap breast reconstruction. This type of reconstruction uses skin and fat from the abdomen to reconstruct a new breast shape. The construct is vascularized through perforating arteries and veins that provide a blood supply to this tissue.

Current techniques to evaluate vessel selection rely on a handheld Doppler used for confirmation of blood flow and perfusion; however, this modality is limited as it only assesses a specific point within the flap.

The S-FLARE imaging system will be used to visualize vascularization in the DIEP flaps, and this study will compare measurements by the S-FLARE imaging system and the standard-of-care ViOptix point probe.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women or men above the age of 21 who are undergoing unilateral breast reconstruction after mastectomy.
Women of childbearing age must have a negative pregnancy test as confirmed by anesthesiologist.

Exclusion Criteria:

BMI > 30.

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

4

Study ID:

NCT01116297

Recruitment Status:

Completed

Sponsor:

Beth Israel Deaconess Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

4

Study ID:

NCT01116297

Recruitment Status:

Completed

Sponsor:


Beth Israel Deaconess Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider